Several methods are used to measure economic impact, including cost-of-illness studies, which estimate the overall economic burden of a disease. Cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) are also employed to evaluate the financial viability of healthcare interventions. CEA compares the relative costs and outcomes of different interventions, while CBA translates health outcomes into monetary terms.
